Galway medical device developer Crospon has secured a global deal for its flagship gastroenterology product, EndoFLIP.
The agreement with Dutch company Medical Measurement Systems will result in Crospon’s first customer shipments into Europe in June.
Medical Measurement Systems is one of the world’s leading companies in the development and distribution of medical gastrodiagnostic systems.
Crospon develops leading-edge minimally invasive medical devices for monitoring, diagnosis and therapy in the gastroenterology area.
The EndoFLIP tool, which is pending US Food and Drug Administration (FDA) approval, was designed by Crospon to provide a more physiologically relevant diagnostic test for gastroesophageal reflux disease (GERD).
Chronic GERD is a prevalent disorder reaching epidemic proportions worldwide that manifests itself as severe heartburn caused by stomach acid refluxing up into the oesophagus.
Crospon’s development of the EndoFLIP system was recently recognised with the 2009 European Gastroenterology Technology Implementation of the Year Award by Frost & Sullivan.
“The international reach, which will be provided by Medical Measurement Systems, will be crucial to the successful rollout of the EndoFLIP product, and we look forward to working with them in the months and years ahead,” Crospon’s CEO John O’Dea (pictured) said.
“The pace of Crospon’s growth over the past six months has accelerated. The establishment of our US operation, CE Mark certification and the recent recognition from Frost & Sullivan means that we are well placed for the challenges of going to market.”
By John Kennedy